Drug Price Trends for AUROVELA

Average Pharmacy Cost for AUROVELA

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
AUROVELA 21 1.5-30 TABLET	65862-0935-21	0.37080	EACH	2025-04-23
AUROVELA 1 MG-20 MCG TABLET	65862-0939-88	0.17102	EACH	2025-04-23
AUROVELA FE 1.5 MG-30 MCG TAB	65862-0941-88	0.14744	EACH	2025-04-23

Market Analysis and Price Projections for Aurovela Fe 1/20

Introduction

Aurovela Fe 1/20 is a progestogen-estrogen combination oral contraceptive, widely used for the prevention of pregnancy. This analysis will delve into the market dynamics, pricing, and future projections for this medication.

Market Overview

Demand and Usage

Aurovela Fe 1/20 is part of the broader market for oral contraceptives, which is driven by the need for effective and convenient birth control methods. The demand for oral contraceptives is consistent, with a large user base among women of reproductive age. The efficacy of Aurovela Fe 1/20, as indicated by its low failure rates when used correctly, contributes to its popularity[1][3][4].

Competition

The market for oral contraceptives is highly competitive, with numerous brands and generic options available. Aurovela Fe 1/20 competes with other combination oral contraceptives, both branded and generic, which can impact pricing and market share.

Pricing and Cost Analysis

Current Pricing

The cost of Aurovela Fe 1/20 varies depending on the pharmacy and the use of discount cards or insurance. For cash-paying customers, a supply of 84 tablets (three 28-day packs) can cost around $32.28, which translates to approximately $0.38 per unit[2].

Discount Programs and Insurance

The use of discount cards, such as the Drugs.com Discount Card, can significantly reduce the cost of Aurovela Fe 1/20, offering savings of up to 80% or more. Additionally, insurance plans often cover a substantial portion of the cost, making the medication more affordable for many users[2].

Factors Influencing Pricing

Manufacturing and Distribution Costs

The cost of production, including the cost of active and inactive ingredients, manufacturing processes, and distribution, plays a crucial role in determining the final price of Aurovela Fe 1/20. Any changes in these costs can impact the pricing strategy.

Regulatory Environment

Regulatory changes and compliance requirements can also influence the pricing of pharmaceuticals. For instance, changes in FDA regulations or healthcare policies can affect the production and distribution costs, thereby impacting the final price to the consumer.

Market Dynamics and Competition

The competitive landscape of the oral contraceptive market is a significant factor in pricing. The availability of generic and branded alternatives can drive prices down as manufacturers compete for market share.

Price Projections

Short-Term Projections

In the short term, the price of Aurovela Fe 1/20 is likely to remain stable, given the current competitive market and the absence of significant changes in manufacturing costs or regulatory environment. The use of discount programs and insurance coverage will continue to make the medication accessible to a wide range of consumers.

Long-Term Projections

In the long term, several factors could influence price projections:

• Generic Competition: As patents expire for similar oral contraceptives, the entry of more generic options could lead to a decrease in prices.
• Regulatory Changes: Any changes in healthcare policies or FDA regulations could impact production costs and, subsequently, the final price to consumers.
• Market Demand: Changes in demand due to shifts in birth control preferences or demographic changes could also affect pricing strategies.

Economic and Social Factors

Economic Factors

Economic conditions, such as inflation and changes in healthcare spending, can impact the pricing of pharmaceuticals. In times of economic instability, consumers may seek more affordable options, which could drive down prices.

Social Factors

Social and cultural attitudes towards birth control can influence demand. Increased awareness and acceptance of oral contraceptives could lead to higher demand, potentially stabilizing or increasing prices.

Adverse Reactions and Contraindications

While not directly impacting pricing, the safety profile of Aurovela Fe 1/20 is crucial for its market position. Adverse reactions and contraindications, such as the risk of liver enzyme elevations with certain hepatitis C treatments, need to be carefully managed to maintain consumer trust and regulatory approval[1][4].

Key Takeaways

• Stable Short-Term Pricing: Prices are likely to remain stable in the short term due to current market conditions.
• Potential Long-Term Decreases: The entry of more generic options and changes in regulatory or economic conditions could lead to lower prices in the long term.
• Importance of Discount Programs: Discount cards and insurance coverage play a significant role in making Aurovela Fe 1/20 affordable for consumers.
• Market Competition: The competitive nature of the oral contraceptive market will continue to influence pricing strategies.

FAQs

What is Aurovela Fe 1/20 used for?

Aurovela Fe 1/20 is used for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

How is Aurovela Fe 1/20 administered?

Aurovela Fe 1/20 is administered in a 28-day regimen, consisting of 21 oral contraceptive tablets and seven ferrous fumarate tablets. The patient takes one tablet daily for 21 consecutive days followed by one week of no tablets[1][3][4].

What are the active ingredients in Aurovela Fe 1/20?

The active ingredients are norethindrone acetate (1 mg) and ethinyl estradiol (20 mcg)[1][3][4].

Can Aurovela Fe 1/20 be used by women over 40?

While oral contraceptives can be used by women over 40, the benefits and risks must be carefully considered, especially for smoking women. Healthy non-smoking women over 40 may find the benefits of oral contraceptive use to outweigh the risks[1].

Are there any significant contraindications for Aurovela Fe 1/20?

Yes, Aurovela Fe 1/20 is contraindicated in females who currently have or have had breast cancer, and it should be discontinued prior to starting certain hepatitis C treatments due to the risk of liver enzyme elevations[1][4].

Sources

1. Drugs.com: Aurovela Fe 1/20: Package Insert / Prescribing Information.
2. Drugs.com: Aurovela Fe 1/20 Prices, Coupons, Copay Cards & Patient Assistance.
3. Medthority: Aurovela 1/20 ETHINYL ESTRADIOL 20 ug/1 Aurobindo Pharma Limited.
4. Medthority: Aurovela 1/20 ETHINYL ESTRADIOL 20 ug/1 Aurobindo Pharma Limited.